Article Information
- Received January 7, 2019
- Revision received April 1, 2019
- Accepted April 27, 2019
- Published online May 22, 2019.
Author Information
- 1Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032
- 2Department of Biochemistry and Molecular Biophysics, Columbia University Irving Medical Center, New York, NY 10032
- 3Medical Scientist Training Program, Columbia University Irving Medical Center, New York, NY 10032
- 4Sulzberger Columbia Genome Center, Columbia University Irving Medical Center, New York, NY 10032
- Correspondence should be addressed to Benjamin D. Hobson at bh2573{at}columbia.edu or Peter A. Sims at pas2182{at}columbia.edu
Author contributions
Author contributions: B.D.H. and P.A.S. designed research; B.D.H. performed research; B.D.H. analyzed data; B.D.H. and P.A.S. wrote the paper.
Disclosures
The authors declare no competing financial interests.
This work was supported by the National Institute of General Medical Sciences Grant T32GM007367 (to B.D.H.), the National Institute on Drug Abuse Grant 1F30DA047775-01 (to B.D.H.), and the National Institute of Neurological Disorders and Stroke Grant R01NS103473 (to P.A.S.). Research reported in this publication was performed in the CCTI Flow Cytometry Core, supported in part by the Office of the Director, National Institutes of Health under Awards S10OD020056. These studies used the resources of the Cancer Center Flow Core Facility funded in part through Center Grant P30CA013696.
Funding
HHS | NIH | National Institute of General Medical Sciences (NIGMS)
T32GM007367HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
R01NS103473HHS | NIH | National Institute on Drug Abuse (NIDA)
F30DA047775
Other Version
- You are viewing the most recent version of this article.
- previous version (May 22, 2019).
Article usage
In this issue
